Trials / Sponsors / Exicure, Inc.
Exicure, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cu Advanced or Metastatic Merkel Cell Carcinoma, Advanced or Metastatic Cutaneous Squamous Cell Carcinoma, Advanced or Metastatic Melanoma | Phase 1 / Phase 2 | 2018-12-13 |
| Completed | A Study of AST-008 in Healthy Subjects Healthy Volunteer Study | Phase 1 | 2017-10-20 |